(2026年2月9日,中国深圳)在近日于美国圣地亚哥举办的2026“未来设施大会”上,国际制药工程协会(ISPE)正式公布2026“年度设施奖”(Facility of the Year Awards,FOYA)入围名单,海普瑞药业凭借坪山新建预灌封制剂智造项目成功入选,是本届入围的全球16强中唯一的中国企业,与赛诺菲、阿斯利康、拜耳、强生、默克等国际制药巨头共同跻身榜单,角逐这一被誉为“医药设施...
Source Link(2026年2月9日,中国深圳)在近日于美国圣地亚哥举办的2026“未来设施大会”上,国际制药工程协会(ISPE)正式公布2026“年度设施奖”(Facility of the Year Awards,FOYA)入围名单,海普瑞药业凭借坪山新建预灌封制剂智造项目成功入选,是本届入围的全球16强中唯一的中国企业,与赛诺菲、阿斯利康、拜耳、强生、默克等国际制药巨头共同跻身榜单,角逐这一被誉为“医药设施...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.